Home › Research › Prevention and risk
Diabetes, Alzheimer's Disease Risk Factors, and the Cafeteria Diet: A Comprehensive Review
Md. Abubakar, Aditi Giri, Falguni Goel, Manshad Khan, Janmejay Gupta, Daksh Kumar, Monika Kaushik, Sachchida Nand et al.. Current Neuropharmacology, 2025-07-10
Topic: Risk, prevention and care in population studies
Plain-language summary
Alzheimer's disease (AD) is a progressive neurodegenerative disorder with multifaceted risk factors, including diet and metabolic dysfunction. The rising prevalence of AD and diabetes has drawn attention to their shared pathophysiological mechanisms. The "cafeteria diet," characterized by high-fat, high-sugar, and energy-dense foods, has emerged as a significant contributor to metabolic dysfunctions, including obesity and insulin resistance, which are risk factors for both diabetes and neurodegenerative diseases. This study explores the effects of the cafeteria diet on cognitive impairment, AD pathology, and its potential role in exacerbating diabetes-related neurological complications. Animal models were subjected to cafeteria diets, mimicking human dietary patterns, to investigate changes in brain structure, amyloid-beta accumulation, tau hyperphosphorylation, and cognitive function. Additionally, metabolic profiling demonstrated the development of insulin resistance and other hallmarks of diabetes, which were closely correlated with the severity of cognitive deficits. Neuropathological analyses revealed exacerbated amyloid-beta accumulation and increased neuroinflammation, linking dietary-induced diabetes to AD pathophysiology. These findings underscore the critical role of dietary habits in modulating the risk and progression of AD, highlighting the importance of interventions targeting metabolic health to mitigate cognitive decline. This study emphasizes the need for further research to unravel the molecular mechanisms underlying the diet-diabetes- AD axis and develop targeted therapeutic strategies.
What this study adds
Evidence grade: Low
This review used animal models to examine how a cafeteria diet of high-fat, high-sugar, energy-dense foods relates to diabetes and Alzheimer's disease pathology. It found the diet produced insulin resistance and was linked to worse cognitive deficits, more amyloid-beta accumulation and increased neuroinflammation, but these are animal findings.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Abubakar, M., Giri, A., Goel, F., Khan, M., Gupta, J., Kumar, D., et al. (2025). Diabetes, Alzheimer's Disease Risk Factors, and the Cafeteria Diet: A Comprehensive Review. Current Neuropharmacology. https://doi.org/10.2174/011570159x384737250626094315
Vancouver
Abubakar M, Giri A, Goel F, Khan M, Gupta J, Kumar D, et al. Diabetes, Alzheimer's Disease Risk Factors, and the Cafeteria Diet: A Comprehensive Review. Current Neuropharmacology. 2025. doi:10.2174/011570159x384737250626094315. PMID: 40635220.
BibTeX
@article{abubakar2025-40635220,
author = {Abubakar, Md. and Giri, Aditi and Goel, Falguni and Khan, Manshad and Gupta, Janmejay and Kumar, Daksh and Kaushik, Monika and Nand, Sachchida and others},
title = {{Diabetes, Alzheimer's Disease Risk Factors, and the Cafeteria Diet: A Comprehensive Review}},
journal = {Current Neuropharmacology},
year = {2025},
doi = {10.2174/011570159x384737250626094315},
pmid = {40635220},
url = {https://doi.org/10.2174/011570159x384737250626094315}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The "cafeteria diet," characterized by high-fat, high-sugar, and energy-dense foods, has emerged as a significant contributor to metabolic dysfunctions, including obesity and insulin resistance, which are risk factors for both diabetes and neurodegenerative diseases.
- Additionally, metabolic profiling demonstrated the development of insulin resistance and other hallmarks of diabetes, which were closely correlated with the severity of cognitive deficits.
- Neuropathological analyses revealed exacerbated amyloid-beta accumulation and increased neuroinflammation, linking dietary-induced diabetes to AD pathophysiology.
- These findings underscore the critical role of dietary habits in modulating the risk and progression of AD, highlighting the importance of interventions targeting metabolic health to mitigate cognitive decline.
Why it matters
This review used animal models to examine how a cafeteria diet of high-fat, high-sugar, energy-dense foods relates to diabetes and Alzheimer's disease pathology. It found the diet produced insulin resistance and was linked to worse cognitive deficits, more amyloid-beta accumulation and increased neuroinflammation, but these are animal findings.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Evidence strengthLow
How this study scored 43/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Current Neuropharmacology) |
| Journal's citation record | 1 / 4 | Current Neuropharmacology: journal h-index 141 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 26 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 8.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 4 / 6 | Cited 14.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 2 / 4 | Cited 26 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Nitesh Kumar: h-index 32 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Banaras Hindu University: institution h-index 401 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 6 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40635220) |
| Free to read | 2 / 2 | Free to read |
| Total | 43 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.2174/011570159x384737250626094315
- PubMed: 40635220
- Original source →
- Free full text: Current Neuropharmacology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Prevention and risk from nearby years
Also in Prevention and risk
269 studies in the library are filed under Prevention and risk with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Prevention and risk hub.